Trademark: 77742056
Status Date
Wednesday, November 24, 2010
Filing Date
Thursday, May 21, 2009
Abandoned Date
Friday, October 29, 2010
1 Biochemicals, namely, secreted proteins used a trimeric therapeutic proteins. New biotechnology technique used to create and produce secreted proteins that can be used as trimeric therapeutic proteins (e.g. soluble receptors, antibodies, vaccines). The process involves gene fusion between a therapeutic polypeptide and a protein trimerazation tag from the C-propeptide domain of collagen (Trimer-Tag), which is capable of self-assembly into a covalently linked trimer. The resulting fusion proteins are then produced in mammalian cells
42 New biotechnology technique used to create and produce secreted proteins that can be used as trimeric therapeutic proteins (e.g. soluble receptors, antibodies, vaccines). The process involves gene fusion between a therapeutic polypeptide and a protein trimerazation tag from the C-propeptide domain of collagen (Trimer-Tag), which is capable of self-assembly into a covalently linked trimer. The resulting fusion proteins are then produced in mammalian cells
Nov 24, 2010
Abandonment Notice Mailed - Failure To Respond
Nov 24, 2010
Abandonment - Failure To Respond Or Late Response
Apr 28, 2010
Notification Of Non-Final Action E-Mailed
Apr 28, 2010
Non-Final Action E-Mailed
Apr 28, 2010
Non-Final Action Written
Mar 24, 2010
Notification Of Final Refusal Emailed
Mar 24, 2010
Final Refusal E-Mailed
Mar 24, 2010
Final Refusal Written
Feb 26, 2010
Teas/Email Correspondence Entered
Feb 26, 2010
Correspondence Received In Law Office
Feb 26, 2010
Teas Response To Office Action Received
Aug 21, 2009
Notification Of Non-Final Action E-Mailed
Aug 21, 2009
Non-Final Action E-Mailed
Aug 21, 2009
Non-Final Action Written
Aug 21, 2009
Assigned To Examiner
May 26, 2009
New Application Office Supplied Data Entered In Tram
May 25, 2009
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
